Erick Lucera is CFO at Dyne Therapeutics, Inc. (DYN). They have made 7 open-market trades across 4 companies since 2017, most recently 2026-08-13.
CIK 0001697616
4 open-market purchases totalling $67K since 2017, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DYN | 119,766 | $1.7M |
| EDIT | 112,720 | $266K |
| XAIR | 43,608 | $98K |
| AITB | 1,171 | $6K |
| VLRX | 4,500 | $1K |
| Total | $2.1M |
Shares reported on the most recent Form 4, priced at the 2026-08-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DYN | SELL · 10b5-1 | 2026-08-13 | 2026-08-17 | $26.28 | $47K | +0.0% | -33.6% | — |
| DYN | SELL | 2026-06-25 | 2026-06-26 | $20.37 | $48K | +14.6% | +21.1% | -22.0% |
| DYN | SELL · 10b5-1 | 2026-05-13 | 2026-05-14 | $18.36 | $27K | +1.7% | +5.2% | +46.7% |
| DYN | SELL · 10b5-1 | 2026-04-01 | 2026-04-03 | $18.64 | $107K | +6.3% | -5.8% | +22.8% |
| EDIT | SELL | 2025-03-04 | 2025-03-05 | $1.71 | $7K | -26.9% | -46.6% | -5.7% |
| XAIR | BUY | 2024-08-14 | 2024-08-15 | $0.40 | $16K | +8.1% | +4.6% | +20.9% |
| EDIT | SELL | 2024-05-20 | 2024-05-22 | $5.61 | $251K | -4.3% | -15.0% | -34.1% |
| XAIR | BUY | 2023-03-16 | 2023-03-20 | $6.82 | $14K | +0.9% | -8.0% | -4.8% |
| VLRX | BUY | 2017-05-22 | 2017-05-23 | $4.95 | $7K | -3.4% | +4.8% | -29.6% |
| VLRX | BUY | 2017-03-23 | 2017-03-27 | $10.00 | $30K | -0.6% | +12.7% | -13.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.